Obstetrics

 
 APOSTEL VIII
 
 Dutch TRUFFLE
 
 2Close
 
 APRIL
 Highlow
 
 PC
 Quadruple P
 
 SIMPLE III
 
 Stop or Go?
 
 STRIDER
 
 SUGAR-DIP
 
 KEUZEHULP IMPLEMENTATIE
 
 INDEX
 MOTHER
 NethOSS
 Ppromexil-III
 ALLO
 AMPHIA
 APOSTEL-I
 APOSTEL-II
 APOSTEL-III
 APOSTEL-IV
 
 Apostel VI
 ASB
 CHIPS
 DIGITAT
 ECV Implementation
 EuFis
 > Fluxim
 GlucoMOMS
 HTA Longterm conseq.
 HTA Preference study
 HYPITAT
 HYPITAT-II
 HyRAS (Hypitat followup)
 Implementatie Tour
 IUPC
 PIMPP
 PPROMCerclage
 PPROMEXIL
 PreCare
 PROBAAT
 PROBAAT-II
 PROBAAT-S
 ProTWIN
 SimpleII
 STAN
 TeMpOH-1
 TeMpOH-3
 TOSTI
 TOTEM
 Triple P
 TRUFFLE
 WOMB study

 ABCD-study
 BIG CHANGE
 CAMPUR
 Cancer in pregnancy
 Doula study
 ECV tocolysis
 ECV Uterine relaxation
 EuroHeartSurvey
 FRUIT
 HP4ALL-PC
 HP4ALL-RS
 IMPACT
 INCAS
 IRIS
 Keizerlijk litteken
 MAKE
 OOPUS
 PRELHUDE
 PROMISES
 RAVEL
 SIMPLE
 STAN followup
 VET study
 VIS-project
 Wat bevalt beter
 ZAHARA II
 ZAHARA 3
 ZOBASII
 

 

Fluxim

 

Hemorrhagia postpartum:  an implementation study on the NVOG guidelines and MOET instructions

 

Go to the Fluxim website.

 

Objective

The most important cause of maternal morbidity in the Netherlands is Hemorrhagia post partum (HPP), with an incidence of 5% containing 10.000 women in the Netherlands a year. Introduction of an evidence-based guideline about HPP by the Dutch society of Obstetrics and Gynaecology (NVOG) and the course Management of Obstetrics Emergencies and Trauma (MOET course) did not lead to a reduction in HPP. This implies the possibility of an incomplete implementation of both the NVOG guideline and MOET-instructions.

 

Study design

To evaluate the implementation of the guideline and MOET instruction in the current care, measurement of the actual care will be performed  in a representative sample of 20 hospitals. This will be done by prospective observation of the third stage of labor of 400 women with a high risk of HPP by using quality indicators extracted from the NVOG guideline and MOET instructions.

Barriers an facilitators for the guideline adherence will be analyzed by performance of semi structured interviews with 30 professionals and 10 patients and a questionnaire among all Dutch gynaecologists and midwives.

In a feasibility study in 4 hospitals a tailor made strategy to implement the NVOG guideline and MOET instructions, based on the outcome of the two studies above, will be tested. In this feasibility study an effect-, process- and cost-evaluation will be performed

 

Study population

All women with a higher risk of HPP:

-HPP in previous delivery

-multiple pregnancy

-polyhydramnion

-chorio-amnionitis

-uterus myomatosis

 -grande multyparity

-long delivery

 -clotting disorders

 -thrombocytopenia (HELLP)

 

Outcome measures

Adherence to the quality indicators regarding the process , structure and outcome of care around childbirth (e.g. incidence of HPP)

Process-measures regarding the degree of making use of and experience with the various parts of the implementation strategy among professionals

 

Costs of the different parts of the implementation strategy

 

Power/data analysis

With an estimation of adherence to the guidelines of 50%, a precision of estimation of guideline adherence of 7.5% and an icc of 0.20, 320 women have to be included in the actual care study

 

Economic evaluation

Cost-evaluation of the different parts of the implementation strategy will be made

 

Time schedule

36 months, 6 months of preparation, 30 months inclusion, interviews,  feasibility study and analysis and report

 

Projectleaders

Dr. H.C.J. Scheepers, UMC Maastricht

Dr. R.P.M.G. Hermens, Center of Quality of Care Research (IQ Healthcare) UMC st Radboud, Nijmegen

 

Projectmembers

Drs. M.Woiski, UMC st Radboud, Nijmegen

Prof. dr. R. Grol, IQ Healthcare, Nijmegen

Prof. dr. F. Lotgering, UMC st Radboud Nijmegen

Dr. A. Middeldorp, LUMC

Prof. dr. J. Kremer, UMC st Radboud Nijmegen

 

Subsidy

ZonMW www.ZonMW.nl

 

Contact

Mallory Woiski, gynaecologist

Tel: 024-3614737

Email: fluxim@studies-obsgyn.nl